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abstract
 
The effects of 0.3–10 nM extracellular protons (pH 9.5–8.0) on ouabain-sensitive rubidium inﬂux
were determined in 4,4
 
 
 
-diisocyanostilbene-2, 2
 
 
 
-disulfonate (DIDS)-treated human and rat erythrocytes. This
treatment clamps the intracellular H. We found that rubidium binds much better to the protonated pump than
the unprotonated pump; 13-fold better in rat and 34-fold better in human erythrocytes. This clearly shows that
protons are not competing with rubidium in this proton concentration range. Bretylium and tetrapropylammo-
nium also bind much better to the protonated pump than the unprotonated pump in human erythrocytes and in
this sense they are potassium-like ions. In contrast, guanidinium and sodium bind about equally well to proto-
nated and unprotonated pump in human red cells. In rat red cells, protons actually make sodium bind less well
(about sevenfold). Thus, protons have substantially different effects on the binding of rubidium and sodium. The
effect of protons on ouabain binding in rat red cells was intermediate between the effects of protons on rubidium
binding and on sodium binding. Remarkably, all four cationic inhibitors (bretylium, guanidinium, sodium, and
 
tetrapropylammonium) had similar apparent inhibitory constants for the unprotonated pump (
 
 
 
5–10 mM). The
 
K
 
d
 
 for proton binding to the human pump, with the empty transport site facing extracellularly is 13 nM, whereas
the extracellular transport site loaded with sodium is 9.5 nM, and with rubidium is 0.38 nM. In rat red cells there
is also a substantial difference in the 
 
K
 
d
 
 for proton binding to the sodium-loaded pump (14.5 nM) and the rubid-
ium-loaded pump (0.158 nM). These data suggest that important rearrangements occur at the extracellular pump
surface as the pump moves between conformations in which the outward facing transport site has sodium bound,
is empty, or has rubidium bound and that guanidinium is sodium-like and bretylium and tetrapropylammonium
are rubidium-like.
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INTRODUCTION
 
The sodium pump harnesses the energy of ATP hydro-
lysis to move sodium ions out of cells and potassium
ions into cells. Extensive kinetic studies of the pump
have provided important evidence in support of the
current kinetic model (Blostein, 1999; Apell and Kar-
lish, 2001). An important feature of the model is that
the exchange of sodium and potassium is ping-pong,
that is, intracellular sodium ions bind, are occluded,
and then released to the outside. After this half cycle is
ﬁnished, extracellular potassium ions bind, are oc-
cluded, and then released to the inside. During the so-
dium half-cycle, the terminal phosphate from ATP is
catalytically transferred to the pump, forming a phos-
phointermediate. During the potassium half-cycle, the
phosphointermediate is hydrolyzed.
 
Like all enzymes, the sodium pump has an optimal
proton concentration. In open membranes, where
the proton concentration on both sides is varied, the
optimal proton concentration is roughly around the
physiological range (40 nM or pH 7.4) (Skou, 1979).
Skou (1979) has shown that increasing the proton
concentration favors the conformation that binds po-
tassium and lowering the proton concentration favors
the conformation that binds sodium. These ATPase
studies were done on open membranes and thus it is
not possible to discern whether the effect is due to in-
tracellular protons or extracellular protons or both.
On the other hand, sidedness can be strongly inferred
from the studies with eosin, even in an unsided prepa-
ration (Skou and Esmann, 1980). In the absence of
ATP, eosin binds to the ATP site and can be used to
monitor the potassium and sodium forms. These stud-
ies clearly showed that intracellular protons favored
the potassium conformation. Equivalently, the results
 
can be stated as saying that the 
 
K
 
d
 
 for protons bind-
ing to a particular residue changes depending on
whether intracellular potassium or sodium is bound
to the pump. In this way, the state of this residue can
provide information about different pump conforma-
tions.
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An increase in extracellular proton concentration
from 40 nM has been shown to lead to proton transport
(Polvani and Blostein, 1988; Dissing and Hoffman,
1990; Goldshleger et al., 1990). Only a few studies have
examined the effect of decreasing extracellular proton
concentration on sodium/potassium exchange by the
sodium pump. Breitweiser et al. (1987), in squid axons,
showed clearly that the predominant effect of protons
in the pH range from 6 to 8 was at the intracellular sur-
face (at saturating extracellular potassium). Recently,
Salonikidis et al. (2000) showed that protons altered
the Km for potassium on the outside and inﬂuenced
the rate of the intermediate charge movement step
during sodium release.
Several organic cations are thought to bind to the
potassium site, including tetrapropylammonium and
bretylium (Kropp and Sachs, 1977; Dzimiri and Al-
motreﬁ, 1992). Bretylium competes with potassium
(Dzimiri and Almotreﬁ, 1992). At low concentrations,
tetrapropylammonium and potassium compete and ex-
tracellular sodium makes tetrapropylammonium in-
hibit better (Kropp and Sachs, 1977). This effect of ex-
tracellular sodium is difﬁcult, if not impossible, to ex-
plain by an interaction of sodium at the transport site.
This is one piece of kinetic evidence in support of an
extracellular sodium modiﬁer site (Kropp and Sachs,
1977). Karlish and coworkers (David et al., 1992; Or et
al., 1993) have found that guanidinium and related
compounds are sodium-like in interactions on the cyto-
plasmic surface.
In this paper, we examine the effects of extracellular
protons, in the range of 0.3–10 nM (pH 9.5–8.0), on ru-
bidium inﬂux. Rubidium is a convenient potassium
congener. Red blood cells allow us to clamp the intra-
cellular proton concentration so that only the extracel-
lular H concentration is varied. We compared the
effect of extracellular protons on the inhibition by
bretylium, guanidinium, sodium, and tetrapropylam-
monium. Remarkably, all these ions have similar appar-
ent inhibitory constants for the unprotonated pump.
In contrast, the protonated pump has dramatically dif-
ferent apparent inhibitory constants for these four
ions. Protons decrease the apparent Ki for tetrapro-
pylammonium 13.4-fold, for bretylium 8.1-fold, and for
guanidinium and sodium only 1.1- and 1.35-fold, re-
spectively. Protons also decreased the kinetic constant
for rubidium 34-fold in human red cells. Thus, bretyl-
ium and tetrapropylammonium are rubidium-like and
guanidinium is sodium-like. In rat red cells, protons
also decreased the kinetic constant for rubidium (13-
fold); in contrast, protons increased the kinetic con-
stant for sodium (7.1-fold). Protons only slightly af-
fected ouabain binding by decreasing the Ki 2.2-fold.
Importantly, protons greatly improved the binding of
extracellular rubidium relative to sodium in both rat
 
and human red cells. These data suggest that impor-
tant rearrangements occur at the extracellular pump
surface as the pump moves between conformations in
which the outward facing transport site has sodium
bound, is empty, or has potassium bound.
 
MATERIALS AND METHODS
 
Human blood was obtained from a consenting volunteer into a
heparinized tube. Rat blood was obtained from Pel-Freez (Arkan-
sas). After removal of plasma and white cells, the red cells were
washed three times in a solution of 165 mM NaCl. Cells were
stored at least overnight at 4
 
 
 
C and for up to 1 wk. The overnight
storage ensures that the Na concentration in the cell is nearly sat-
urating (typically 
 
 
 
40 mM in our hands). On the day of the mea-
surement, the cells were incubated in a solution containing 150
mM NaCl, 20 mM HEPES, and 10 mM glucose for 1 h in order to
be sure the ATP concentrations were restored. K was omitted in
order to keep the cell Na high. The cells were treated with 0.1
mM 4,4
 
 
 
-diisocyanostilbene-2, 2
 
 
 
-disulfonate (DIDS)* in the same
media for 15 min. Normal red blood cells rapidly equilibrate pro-
tons, primarily via chloride/bicarbonate exchange. DIDS inhibits
this exchange and the residual proton ﬂux is very small (Jen-
nings, 1978; Wieth et al., 1980). The substantial buffering ca-
pacity of hemoglobin easily prevents any intracellular proton
concentration change due to the small proton inﬂux. Thus, it
is possible, using DIDS treated red blood cells, to clamp the in-
tracellular pH and vary only the extracellular pH (Xu and Rou-
fogalis, 1988; Milanick, 1990; Dissing and Hoffman, 1990; Xu et
al., 2000.). In control experiments, we measured the pH in lysed
DIDS-treated red cells before and after incubation for 10 min at
pH 9.28 (the highest pH used in these studies). After the incuba-
tion, the cells were washed in unbuffered Mg(NO
 
3
 
)
 
2
 
 and then
lysed and the pH measured with a pH electrode. There was no
signiﬁcant difference in the intracellular pH.
After the DIDS treatment, the cells were then washed three
times in 110 mM Mg(NO
 
3
 
)
 
2
 
 and placed into ﬂux media. Ni-
trate was used so that there would be no chloride-dependent
rubidium ﬂux, thus reducing the ouabain-insensitive compo-
nent of the ﬂux. The media contained 0.1 mM DIDS, 0.3 mM
Rb (except Fig. 7 where the indicated concentrations were
used), 
 
86
 
Rb, 62 mM Mg(NO
 
3
 
)
 
2
 
, and 100 mM N-methyl-D-glu-
camine TAPS, titrated to the indicated proton concentrations.
The ﬁnal concentration of red cells was 
 
 
 
1%. The tubes were
incubated at 37
 
 
 
C for 10 min. The ﬂux was stopped by adding
ice cold 137 mM Na
 
2
 
SO
 
4
 
 and the cells spun down. They were
washed two additional times in the same media and the
amount of 
 
86
 
Rb in the pellet determined with a scintillation
counter. In preliminary experiments, we found that the oua-
bain-insensitive ﬂux was independent of the proton concentra-
tion, thus we only measured the ﬂux in the presence of oua-
bain at the lowest proton concentration studied in each exper-
iment (0.5 nM except for one experiment in Fig. 3) and used
that measurement to determine the ouabain-sensitive ﬂux at
all proton concentrations.
 
Kinetic Analysis
 
For this analysis, we assume that the binding of rubidium and
each inhibitor are mutually exclusive. (Competition is a subset of
mutually exclusive.) The equation also assumes that both the in-
hibitor (I) and the proton (H) can be bound to the pump and
 
*
 
Abbreviations used in this paper:
 
 DIDS, 4,4
 
 
 
-diisocyanostilbene-2, 2
 
 
 
-
disulfonate. 
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that they can bind in random order. Protons and rubidium (Rb)
are also assumed to bind in random order.
 
1
 
 The data were ana-
lyzed using the following equation with Kaleidagraph Software
(Synergy Software, Reading, PA).
vH A B H × + [] ⁄ () , =
 
where A 
 
 
 
 c 
 
 
 
 d 
 
 
 
 I and B 
 
 
 
 e 
 
 
 
 f 
 
 
 
 I and c 
 
  
 
L
 
Rb
 
 
 
 
 
 K
 
H
 
/K
 
Rb
 
(1 
 
 
 
 K
 
Rb
 
/Rb); d 
 
  
 
L
 
Rb
 
 
 
  
 
K
 
H
 
/Rb 
 
 
 
 (I/Ki); e 
 
 
 
 1 
 
 
 
 L
 
Rb
 
/Rb;
f 
 
 
 
 (L
 
Rb
 
/Rb) 
 
 
 
 (I/Li).
This equation is essentially the same as in Segel (1975) ex-
cept for the use of L
 
Rb
 
 and Li instead of 
 
 
 
 
 
  
 
K
 
Rb
 
 and 
 
 
 
 
 
  
 
Ki. In
general, the constants are functions of rate constants from
many steps in the cycle. However, if the binding of proton, ru-
bidium, and inhibitor were in rapid equilibrium and if the
rate limiting step followed their binding (e.g., rubidium deoc-
clusion), then K
 
H
 
 is the dissociation constant for protons and
K
 
Rb
 
 and L
 
Rb
 
 are the dissociation constants for rubidium for the
unprotonated pump and protonated pump, respectively. Ki
and Li are the dissociation constants for the inhibitors (bretyl-
ium, guanidinium, ouabain, sodium, and tetrapropylammo-
nium) for the protonated and unprotonated pump, respec-
tively.
All experiments were done in triplicate. We used individual
data from each experiment for ﬁtting but plotted the average
value and standard error for each set of triplicates at each con-
centration for clearer display.
Figure 1. Extracellular pro-
ton activation of 86Rb inﬂux
as a function of rubidium.
Ouabain-sensitive Rb inﬂux
was determined as described
in  materials and methods
in DIDS-treated red blood
cells. The DIDS treatment ef-
fectively clamps the intracel-
lular proton concentration,
so that the observed effect is
due to extracellular protons.
Three complete experiments
were run for both rat (a) and
human (b) red cells. Each ex-
periment included all the
proton concentrations shown
in the ﬁgures and all 4 rubid-
ium concentrations as indi-
cated in each panel. The data
on each day were normalized
to the ﬂux at the highest pro-
ton and rubidium concentra-
tions. The data from the 3 ex-
periments were then pooled
and the mean and standard
deviations are shown. The
data (not the means) were ﬁt
to the equation, v   H/[A  
B   H] at each rubidium con-
centration. The replots of A
and B versus 1/Rb are shown
in Fig. 2.
 
1
 
We did attempt to fit the data to an ordered model. A model in which
protons must bind before rubidium or tetrapropylammonium binds pro-
vided an adequate fit of most of the data, but was not as good a fit (in
terms of sum of squares of the error) as a random order model. Although
our data are better fit by the random ordered model, we do not feel we
have completely eliminated such an elegant model as the ordered model
for proton binding before rubidium and tetrapropylammonium. We
have chosen to present a random ordered model for our analysis as this is
the most conservative approach; an ordered model in which protons
must bind before rubidium or tetrapropylammonium could be consid-
ered a subset of the random ordered model, where protons increase
binding infinitely, in contrast to the 34- and 13-fold observed here. 
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Materials
 
Guanidium (guanidine) nitrate (AC215310010) was purchased
from Fisher Scientiﬁc and all reagents were obtained from Fisher
Scientiﬁc or Sigma-Aldrich.
 
RESULTS
 
In all the following experiments, ouabain-sensitive 
 
86
 
Rb
inﬂux was determined in DIDS-treated red blood cells
as a function of the extracellular proton concentration.
We measured the pH of DIDS-treated cells and found
that after 10 min in a pH 9.2 medium, the pH inside
the red cells changed by 
 
 
 
0.1 pH units, thus conﬁrm-
ing that the intracellular proton concentration was ef-
fectively clamped at 40 nM (pH 7.4) for at least 10 min
in DIDS-treated red cells. This is expected because
DIDS-treated red cells have a very low proton perme-
ability and the buffer capacity of hemoglobin is very
high (unpublished data).
The effect of rubidium on proton activation of the
pump was determined in human and rat red blood
cells (Fig. 1). If protons and rubidium were competing
at the rubidium transport site, or were mutually exclu-
sive, then rubidium would increase the K
 
1/2
 
 for pro-
tons, which is not observed. Rather, rubidium de-
creased the apparent K
 
1/2
 
 for protons in both species.
To determine the kinetic constants for rubidium bind-
ing to the unprotonated pump, K
 
Rb
 
, and the proto-
nated pump, L
 
Rb
 
, we ﬁt these data to the equation,
ﬂux 
 
 
 
 H/[A 
 
 
 
 B 
 
 
 
 H], where A and B are functions of
1/Rb. The equation H/[A 
 
 
 
 B 
 
 
 
 H] is equivalent to
the more conventional Vmax H/[Km 
 
 
 
 H] with A 
 
 
 
Km/Vmax and B 
 
 
 
 1/Vmax. One advantage of the A
and B formulation is that A contains the kinetic con-
Figure 2. Replot of A and B versus
1/[Rb]. The values of A and B were de-
termined from the data in Fig. 1. The
values for A have been normalized so
that the y intercept is 1. By doing this,
the slope of the line for A is propor-
tional to KRb; in the rapid equilibrium
case, this reﬂects rubidium binding to
the unprotonated pump. As shown in
materials and methods, the line for B
is theoretically expected to have a y in-
tercept of 1. The slope for B is propor-
tional to LRb; in the rapid equilibrium
case, this reﬂects rubidium binding to
the protonated pump. Clearly, protons
greatly increase the afﬁnity of the pump
for rubidium. The slopes were 0.868  
0.101 for A (open diamonds) and
0.066    0.0059 for B (closed dia-
monds) for rat red blood cells (a) and
were 1.32   0.07 for A (open circles)
and 0.0387   0.0074 for B (closed cir-
cles) for human red blood cells (b). 
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stants in the absence of H and B contains the kinetic
constants at saturating H. In particular, A contains the
kinetic constant for rubidium binding to the unpro-
tonated pump (K
 
Rb
 
) and B contains the kinetic constant
for binding to the protonated pump (L
 
Rb
 
). This means
that the kinetic constants are more directly calculated
from A and B and this approach avoids the artifactual
compilation of errors that would occur if we ﬁrst ﬁt to
ﬁnd Km and Vmax and then calculated Km/Vmax.
The kinetic constants were obtained from a replot of
A and B versus the reciprocal of the Rb concentration
(Fig. 2). In the rat red cells, from the slopes and inter-
cept we determine that K
 
Rb
 
, a measure of rubidium
binding to the unprotonated pump, is 0.87 
 
 
 
 0.1 mM
and that L
 
Rb
 
, a measure of rubidium binding to the
protonated pump, is 0.066 
 
 
 
 0.006 mM. Thus, protons
substantially improve the binding of rubidium to the
pump; in a simple rapid equilibrium model protons
make rubidium bind 
 
 
 
13-fold better in rat red cells.
K
 
H
 
, a measure of proton binding to the pump in the ab-
sence of rubidium, was 2.11 nM in the rat and was
about sixfold greater in human, 13 nM. In human, pro-
tons had an even greater effect on the binding of rubid-
ium; in a simple rapid equilibrium model protons
 
make rubidium bind 
 
 
 
34 fold better in human red
cells. This is the result of a higher kinetic constant for
rubidium in the absence of protons, K
 
Rb
 
 
 
 
 
 1.32 
 
 
 
 0.07
mM, and a lower kinetic constant for rubidium in the
presence of protons, L
 
Rb
 
 
 
 
 
 0.0387 
 
 
 
 0.0074 mM. Thus,
it is clear that in both species, contrary to the expecta-
tion that protons and rubidium might compete, pro-
tons make rubidium bind substantially better.
We wanted to determine if protons had similar ef-
fects on the binding of other cationic inhibitors. Thus,
we compared the effect of extracellular protons on the
inhibition by four cations in human red cells: bretyl-
ium, guanidinium, sodium, and tetrapropylammonium
at a ﬁxed concentration of rubidium (0.3 mM). On
each day, we measured the ﬂux at seven different extra-
cellular proton concentrations (0.3–10.3 nM) and four
different inhibitor concentrations (0–10 mM for tetra-
propylammonium and bretylium, 0–30 mM for sodium,
0–82.5 mM for guanidinium). The results for the four
cationic inhibitors are shown in Fig.3.
To compare the inhibition constants for binding to
the unprotonated pump (Ki) and to the protonated
pump (Li), we ﬁt the data to the equation: H/[A 
 
 
 
 B 
 
 
 
H]. In this formulation, A contains the inhibitor con-
Figure 3. Extracellular proton activation of 86Rb inﬂux at different inhibitor concentrations. Ouabain-sensitive 86Rb inﬂux was deter-
mined as described in the methods in DIDS treated human red blood cells at 0.3 mM rubidium. Three complete experiments were run
for each inhibitor, which included all the proton concentrations shown in the ﬁgures and all 4 inhibitor concentrations as indicated in
each panel and the data pooled as indicated in the legend to Fig. 1.The data (not the means) were ﬁt to the equation, v   H/[A   B   H]
at each inhibitor concentration. The replots of A and B versus I are shown in Fig. 4, a and b.502 Extracellular Protons and the Sodium Pump
stant for binding to the unprotonated pump and B
contains the inhibitor constant for binding to the pro-
tonated pump. Fig. 4 A shows a replot of A   c   d   I
versus I for the four inhibitors. As shown in methods,
the conventional kinetic equation has H and Rb terms
in both numerator and denominator, as they are activa-
tors, and inhibitor terms only in the denominator.
Thus, replots for the activator, Rb, are linear in the re-
ciprocal of the rubidium concentration and replots for
the inhibitors are linear in the inhibitor concentration.
The y intercept values for the four inhibitors studied in
human red blood cells are very similar, as expected be-
cause c   LRb   Kh/KRb   (1   KRb/Rb), which merely
reﬂects the properties of the transporter without inhib-
itor bound. Remarkably, the slopes for all these inhibi-
tors are also very similar, despite the great structural
differences. The slopes are equal to LRb   KH/(Rb  
Ki). The only term that depends upon the inhibitor is
Ki, which is the inhibitory constant for the unproto-
nated pump. (With rapid equilibrium and the rate-lim-
iting step following proton and rubidium binding, Ki
would be the Kd.) Since the slopes are so similar, we
conclude that all these ions bind to the unprotonated
pump with similar Ki.
Fig. 4 B shows a replot of B   e   f   I vs. I for the
four cationic inhibitors. Once again, the y intercept val-
ues, e, are very similar, as expected because the y inter-
cept should merely reﬂect the properties of the trans-
porter without inhibitor bound. Strikingly the slopes
are very different. The slopes include the factor LRb/ru-
bidium and the respective Li for inhibitor binding to
the protonated pump. Clearly, the protonated pump
has different apparent afﬁnities for these inhibitors;
the protonated pump binds bretylium and tetrapropyl-
ammonium about an order of magnitude better than
guanidinium and sodium.
We also wanted to examine an extracellular inhibitor
that would not bind at the transport site and we chose
to examine ouabain. Because ouabain binding and dis-
sociation are slow in human red blood cells and we
wished to apply steady-state inhibition analysis, ouabain
inhibition was examined in rat red blood cells. The ef-
fect of ouabain on the proton activation curves is
shown in Fig. 5 A and the replot of A and B versus oua-
bain is shown in Fig. 5 B (note that the x-axis is micro-
molar in this case and not millimolar as was the case for
the cationic inhibitors). We also determined the kinetic
constants for Na inhibition of Rb inﬂux in rat red cells
(Fig. 5, C and D); the analysis was similar to that pre-
sented for human red blood cells above, except that
higher Na concentrations (0, 20, 60, and 82.5 mM)
were used, in order to get signiﬁcant inhibition.
The slopes of the lines in the replots of Fig. 4 and Fig.
5, B and D, for binding to protonated and unproto-
nated pump cannot be directly compared because the
slopes include the kinetic constants for Rb binding to
the unprotonated pump (A) and the protonated pump
(B). The inhibitory constants t for the unprotonated
pump and protonated pump were calculated from the
Rb kinetic constants determined in Figs. 1 and 2 and
the replot slopes determined in Figs. 4 and 5 using the
equations in materials and methods. As can be seen
in Fig. 6, protons have little or no effect on sodium and
guanidinium kinetic constants and have a very large ef-
fect on bretylium, tetrapropylammonium, and rubid-
ium kinetic constants binding in human pumps. The
Figure 4. (a) Replot of A for bretylium, guanidinium, sodium,
and tetrapropylammonium versus inhibitor concentrations. The
values of A were determined from the plots in Fig. 3. The slope of
this line is proportional to the Ki for each inhibitor, for binding to
the unprotonated pump. All four lines have similar slope, imply-
ing that all four inhibitors bind with similar afﬁnity to the unpro-
tonated pump. The slopes were: bretylium (triangles), 0.392  
0.078; guanidinium (diamonds), 0.175   0.014; sodium (circles),
0.271   0.037; tetrapropylammonium (squares), 0.364   0.063.
(b) Replot of B for bretylium, guanidinium, sodium, and tetrapro-
pylammonium versus inhibitor concentrations. The values of B
were determined from the plots in Fig. 3. The slope of this line is
proportional to the Li for each inhibitor, for binding to the proto-
nated pump. Clearly Na and guanidinium have very little afﬁnity
for the protonated pump and bretylium and TPA have substantial
afﬁnity. The slopes were: bretylium (triangles), 0.282   0.019;
guanidinium (diamonds), 0.016   0.001; sodium (circles), 0.040  
0.006; tetrapropylammonium (squares), 0.517   0.016.503 Milanick and Arnett
effect on ouabain binding in rat is intermediate be-
tween sodium and rubidium.
These results make what may appear to be a paradox-
ical prediction in human pumps: even though the inhi-
bition constants for sodium are only slightly altered by
protons, the inhibition by sodium will be strongly pH
dependent and even though the inhibition constants
for tetrapropylammonium depend strongly on protons,
the tetrapropylammonium inhibition will be nearly pH
independent. This paradoxical prediction was tested in
the experiments shown in Fig. 7, where the effect of ex-
tracellular protons on the inhibition by tetrapropylam-
monium and sodium was determined in the same ex-
periment. It can be seen that protons have little effect
on the inhibition by tetrapropylammonium. In con-
trast, protons dramatically reduce the inhibition by so-
dium. Clearly, it would be misleading to conclude from
these experiments, however, that protons decrease the
inhibition constant for sodium and have no effect on
the inhibition constant for tetrapropylammonium. It is
misleading because protons are also affecting rubidium
binding (compare control line).
The summary data in Fig. 6 show that protons increase
the binding of rubidium and tetrapropylammonium ap-
proximately equally. When the proton concentration in-
creases, one would expect tetrapropylammonium to bind
better in the absence of rubidium. In our ﬂux experi-
ments, we necessarily examine the competition between
rubidium and tetrapropylammonium. Since protons
make both rubidium and tetrapropylammonium bind
better, the outcome is essentially no effect of proton con-
centration on tetrapropylammonium inhibition of pump
ﬂux. In contrast, protons have little effect on sodium
binding, but as protons increase, rubidium binds better,
so sodium cannot bind, and therefore there is less inhibi-
tion as protons increase. This analysis rests on the reason-
able assumption that rubidium and tetrapropylammo-
nium and sodium bind in a mutually exclusive manner in
this concentration range. (Competition at a common site
is a subset of mutually exclusive models.)
Figure 5. The effect of ouabain and sodium on the proton activation of Rb inﬂux in DIDS treated rat red blood cells. The experimental
procedure was similar to that described in Fig. 3 and the results of 3 separate experiments pooled as described in Fig. 3. The data were ﬁt
to the equation, v   H/[A   B * H] at each inhibitor concentration (panels a and c) and the values of A and B replotted vs. I (panels b
and d). Note that the x axis for ouabain is in micromolar in this panel b, reﬂecting the substantially higher afﬁnity for ouabain than for the
sodium and the inhibitors in Fig. 4. The slope for ouabain binding in the absence of protons was 0.0566   0.0043 and in the presence of
protons was 0.0124   0.0023. The slope for ouabain binding in the absence of protons was 0.17   0.011 and in the presence of protons
was 0.12   0.012.504 Extracellular Protons and the Sodium Pump
DISCUSSION
In this paper we have shown that protons alter the inhi-
bition by tetrapropylammonium and bretylium differ-
ently from guanidinium and sodium. We have deter-
mined that the inhibitory constants for these ions are
similar for the unprotonated carrier. In contrast, the
protonated pump binds tetrapropylammonium and
bretylium about an order of magnitude better than so-
dium and guanidinium. In addition, rubidium binds
 13-fold and 34-fold better to the protonated pump in
rat and human pumps, respectively. Ouabain binds
with higher afﬁnity than the other inhibitors and while
protons slightly decrease the binding, the effect is less
than observed for sodium and in the opposite direction
from that of rubidium. These data suggest that there is
an extracellular titratable residue whose environment
depends upon which ion is bound to the extracellular
transport site.
Two previous studies have examined the effect of ex-
tracellular protons in the alkaline range on the so-
dium/potassium exchange mediated by the sodium
pump. Our results are consistent with these studies. In
squid giant axons, Breitweiser et al. (1987) and, in Xe-
nopus oocytes, Salonikidis et al. (2000) found that, at
saturating extracellular K, extracellular proton concen-
tration had little effect on the pump. As shown in Fig.
2, our results are consistent with models in which extra-
cellular protons have only a slight effect on Vmax. Sa-
lonikidis et al. (2000) also studied the effect of protons
at less than saturating extracellular potassium and they
found that an increase in proton concentration from
10 to 100 nM (pH 8 to 7) caused a twofold increase in
apparent Km when the membrane potential was zero.
In contrast, we ﬁnd that from 0.5 to 10 nM (pH 9.3 to
8.0) the apparent Km for Rb decreases. This difference
could reﬂect a species or temperature dependent dif-
ference. Alternatively, a plot of Km vs. pH could be bell
shaped, with a plateau at pH 8.0 and each study exam-
ined a different half of the bell-shaped curve.
Skou (1979) in ATPase measurements where the pro-
ton concentration varied on both sides found that pro-
tons increase the afﬁnity for potassium. This is similar
to our results. It is difﬁcult to determine whether the
ATPase effects observed by Skou were at intracellular
or extracellular sites. Our data are consistent with the
interpretation that they could occur at extracellular
sites. In contrast, the proton dependence of eosin bind-
ing clearly reﬂects intracellular sodium and potassium
binding sites and it is simplest to imagine that the pro-
ton effects are also intracellular (Skou and Esmann,
1980). The eosin binding studies clearly show that pro-
tons increase the afﬁnity for intracellular potassium
and our results clearly show that extracellular protons
increase the afﬁnity for extracellular rubidium. Inter-
estingly, Breitweiser et al. (1987) found that intracel-
lular protons increase the afﬁnity for extracellular ru-
bidium.
Since protons also made rubidium bind about an or-
der of magnitude better, tetrapropylammonium and
bretylium behave like rubidium, and guanidinium be-
haves like sodium with respect to their proton depen-
dence.
Rat Versus Human
The fundamental ﬁnding that protons affect the bind-
ing of rubidium and sodium differently is found in
both human and rat red cells. Although the kinetic pa-
rameters for Rb binding are slightly different in the rat
and the human, protons make Rb bind better in both
species, but the effect is larger in human. In contrast,
Figure 6. The effect of
protonation on the kinetic
constants for bretylium,
guanidinium, ouabain, ru-
bidium, and sodium. The
values of Ki and Li were cal-
culated as indicated in the
text and normalized to the
value of Ki. The cations fall
into two categories: cate-
gory one includes tetrapro-
pylammonium, bretylium,
and rubidium. Their kinetic
constants are substantially
decreased by protonation.
In a simple model where
these kinetic constants re-
ﬂect the afﬁnity, this im-
plies that protons make
these ions bind much bet-
ter. Category two includes guanidinium and sodium. In human, their kinetic constants are little changed by protonation; in rat,
the kinetic constant for sodium is substantially increased. Ouabain is intermediate between sodium and rubidium in rat.505 Milanick and Arnett
protons have little effect on sodium binding in hu-
mans, but have a larger effect (and in the opposite di-
rection as for rubidium) in rat.
Another way to examine the data is to ask how do so-
dium and potassium alter the proton interaction with
the pump. Protons bind  13-fold better to the rat
pump than to the human pump in the absence of so-
dium and potassium (unloaded pump). In human
pumps, protons bind  34-fold better to the rubidium-
loaded pump than unloaded pump and about equally
well (1.34-fold) in the presence or absence of sodium
(sodium-loaded pump vs. unloaded pump). Thus, pro-
tons bind  34/1.34   25-fold better to the rubidium-
loaded pump than to the sodium-loaded pump and it is
this property that is closely matched in rats: protons
bind   13-fold better to the rubidium-loaded pump
than the unloaded pump and about sevenfold less well
to the sodium-loaded pump than the unloaded pump.
Thus, in rat there is also a substantial preference (13  
7   91-fold) in proton binding to the rubidium-loaded
pump than to the sodium-loaded pump.
Ouabain Versus Cations
Although we were able to classify the cationic inhibitors
into two classes: those which bound much better to the
protonated pump and those that bound about the
same, or less well, to the protonated pump than to the
unprotonated pump, ouabain did not seem to ﬁt into
either class. Potassium is known to be antagonistic to
ouabain binding. It is interesting that rubidium de-
creased the kinetic constant for protons 13-fold, but
ouabain had an effect, while small, in the opposite di-
rection, increasing the kinetic constant for protons 2.2-
fold. The effect of ouabain was in the same direction as
the effect of sodium (to increase the kinetic constant
for protons), but sodium had a much greater effect
(sevenfold). These values are consistent with the idea
that the pump conformation is different with ouabain
bound than with rubidium or sodium bound.
Models for Proton Regulation of the Pump
There are two classes of models to consider for the ef-
fect of protons: (a) protons alter extracellular cation
dissociation constants or (b) protons alter a rate con-
stant for steps not involving extracellular cation bind-
ing and dissociation (e.g., sodium translocation or the
opening of the Rb occlusion gate to the inside). We
consider each of these models in turn.
Protons Alter the Extracellular Cation Dissociation Constant
In this model, protons bind to an extracellular residue
and alter the binding of extracellular cations. For sim-
plicity, we will assume that the Ki values are the Kd val-
ues. In models where Ki does not equal Kd, the addi-
tional rate constants in Ki reﬂect properties of the
pump that are independent of the inhibitor and thus
will not alter the conclusions about how the inhibitors
are different. Also we assume that sodium is a dead end
inhibitor, like tetrapropylammonium, bretylium, and
guanidinium. This is a reasonable assumption because
the red cells will have a low concentration of ADP, so
that the ADP release step, which occurs during the so-
dium efﬂux half cycle, is essentially irreversible (Kap-
lan, 1985).
Our analysis clearly shows that protons greatly de-
crease the apparent Kd for tetrapropylammonium, ru-
bidium and bretylium and have only a slight effect on
sodium and guanidinium. This seems a little puzzling if
all these ions are going to the same site. However, the
analysis can also be stated as, the Kd for protons de-
pends upon which cation is bound to the site. This is
easy to picture if the protonated residue is outside of
Figure 7. Extracellular protons inﬂu-
ence the inhibition by sodium more
than the inhibition by tetrapropylam-
monium. Ouabain-sensitive 86Rb inﬂux
was determined as described in materi-
als and methods in DIDS-treated red
blood cells. Shown are the mean and
standard deviation of a representative
experiment of a total of three that were
done under these conditions. In this ex-
periment, the slope in the absence of
inhibitor (circle) was 0.447   0.055, in
the presence of 0.5 mM tetrapropylam-
monium (triangle) was 0.149   0.032,
and in the presence of 22.5 mM sodium
(square) was 0.212   0.006. The slope
of ﬂux versus proton concentration was
statistically signiﬁcantly different for tet-
rapropylammonium and for sodium in
all three experiments.506 Extracellular Protons and the Sodium Pump
the transport pocket. A change of Kd implies that the
residue has an altered environment. It would not be
surprising that there would be allosteric differences
in the extracellular protein surface depending on
whether tetrapropylammonium, rubidium, bretylium,
guanidinium, or sodium are bound. The relative
changes of Kd for these different states are shown in
Fig. 8. This model is the simplest explanation of our
data and provides an important distinction between the
sodium conformation and the potassium conforma-
tion.
Figs. 6 and 8 illustrate our ﬁnding that extracellular
cationic inhibitors of the Na pump fall into two classes:
those whose inhibition is greatly increased by protona-
tion of the pump (tetrapropylammonium and bretyl-
ium) and those whose inhibition is virtually unaffected
by protonation (sodium and guanidinium). In con-
trast, ouabain binding does not fall into either cate-
gory, which is not surprising since it does not bind at
the transport site. Nevertheless, ouabain binding does
alter the Kd for protons.
Because extracellular sodium ions potentially have
three different roles other models are possible. There
are three different types of interactions that have been
proposed for extracellular sodium. (a) Extracellular so-
dium is a product of the forward pump cycle and there-
fore would bind as a product inhibitor. (Note that no
Na/Na exchange is likely under our conditions be-
cause these are well fed red blood cells and the ADP
should be low [Kaplan, 1985].) (b) Extracellular so-
dium can substitute for potassium on the forward
pump cycle, in which case the pump stoichiometry is
3Na/2Na and the ﬂux is electrogenic (Cornelius and
Skou, 1985). In wild-type pumps, this rate is very slow.
(c) Extracellular sodium has been proposed to bind to
a modiﬁer site. Two examples are the effect of sodium
to increase the binding of tetrapropylammonium and
to decrease the inhibition by vanadate (Kropp and
Sachs, 1977; Sachs, 1987).
Could the effect of sodium observed here be at the
putative modiﬁer site? If so, then there is no need
(based on the current data) to design a model in which
proton binding alters the transport site afﬁnity for ru-
bidium differently from sodium. Why? The Kd for the
extracellular residue is 13 nM for the empty, outward-
facing transport site, and changes substantially (at least
eightfold) when the transport site is loaded with tetra-
propylammonium, bretylium, or potassium. One can
Figure 8. Reaction scheme
for extracellular cations bind-
ing to the Na pump. The
scheme depicted describes
the enzyme conformation
that has just translocated and
released Na to the extracellu-
lar space. We have purpose-
fully omitted references to E1
and E2 as they are sometimes
used to describe different
pump conformations. Also,
this model assumes that ru-
bidium and sodium are mutu-
ally exclusive. Rubidium
binds much better to the pro-
tonated pump than the un-
protonated pump, 13-fold
better in rat (a) and 34-fold
better in human (b). In con-
trast, sodium binds only 1.34-
fold better to the protonated
pump than the unprotonated
pump in human. In rat, the
effect of protons is in the op-
posite direction, making so-
dium bind sevenfold less well.
In both species, the addition
of protons greatly increases
the selectivity of the pump for
rubidium over sodium. Stated
another way, the pK changes
substantially in both species when rubidium binds instead of sodium. The reaction scheme shows the Kd values for proton binding to the
different cation loaded, outward facing, conformations and also the pK values. Values obtained from Figs. 2, 4, 5, and 6, using the equa-
tions in materials and methods as described in the text.507 Milanick and Arnett
conveniently assume that a similar change takes place
when sodium binds to the transport site, since in this
modiﬁer site model, that effect was not studied here. In
this modiﬁer site model, the Kd changes only slightly
when sodium or guanidinium is bound at the modiﬁer
site. Thus, in the modiﬁer-site model, a large pK
change of the residue occurs because its local environ-
ment is substantially altered when any of the tested ions
are bound to the transport site but only slightly altered
when sodium or guanidinium is bound to the modiﬁer
site. In addition, this model requires that the binding
of sodium to its modiﬁer site increases the afﬁnity for
tetrapropylammonium (Kropp and Sachs, 1977), and
that the binding of proton to its modiﬁer site also in-
creases the afﬁnity for tetrapropylammonium but that
protons and sodium do not compete at this site. In ad-
dition, since guanidinium has an effect similar to so-
dium, it would appear that guanidinium goes to the
modiﬁer site in this model.
Proton Switch?
Could the proton be important in determining if the
pump treats extracellular sodium as a product inhibitor
or treats extracellular sodium as a potassium surrogate?
This is an interesting possibility and makes important
predictions about the pH dependence of 3Na/3Na ex-
change versus 3Na/2Na exchange. Because, in wild-
type pump, the 3Na/2Na exchange is very slow, it may
not be possible to test this directly. In the E779A mu-
tant, 3Na/2Na exchange is nearly as fast as 3Na/2K ex-
change and is readily measured (Koster et al., 1996; Pe-
luffo et al., 2000). It is possible that this mutant results
in a change of the Kd for the extracellular proton site.
This change of Kd would then alter the bias of the
pump from sodium-as-product to sodium-as-surrogate-
potassium. Experiments are in progress to test this
model.
Elegant data from several labs clearly provides evi-
dence for a conformational difference in the pump
when it binds extracellular sodium compared with ex-
tracellular potassium (Gadsby et al., 1993; Hilgemann,
1994, 1997; DeWeer et al., 2001). The binding of two
sodium ions causes an access well to close and then the
third extracellular sodium ion must traverse this well to
its binding site.2 Our data that the Kd for proton
changes provides clear evidence for a conformational
difference in the pump when it binds extracellular so-
dium compared with extracellular potassium. It would
be most economical if the conformation change that
the proton detects and the access well conformational
change were the same conformational change. We con-
sider two cases: that the protonated residue is inside
the access well and that it is outside the access well.
Could the Kd change observed here reﬂect the
change of environment of a residue inside the access
well? We think that is unlikely. For this model, we as-
sume that, under our conditions, the binding of so-
dium closes the access well. This closing would be ex-
pected to alter the local environment of residues inside
the access well and yet we did not observe a change of
Kd for proton in the presence of sodium compared with
the Kd for proton for the empty transport site.
Could the Kd change observed here reﬂect the
change of environment of a residue outside the access
well that occurs when the access well closes or opens?
This also seems unlikely. Start by considering the empty
outward facing transport site. It has a Kd of 13 nM. In
this model, when sodium binds, the access well closes
and yet the Kd remains nearly the same (12 nM). On
the other hand, when potassium binds (and presum-
ably the access well does not close) there is a large
change of Kd (to 0.4 nM). Thus, the large change of Kd
occurs on potassium binding, not sodium binding, but
the access well changes on sodium binding and pre-
sumably not potassium binding. What does occur on
potassium binding is occlusion of potassium. But a sim-
ilar change of Kd occurs with tetrapropylammonium
and bretylium (to 1.6 and 1 nM respectively). Tetrapro-
pylammonium does not become occluded (Forbush,
1988), so the change of Kd occurs before the conforma-
tional change for occlusion.
Protons Alter a Rate Constant
An alternative model of the effect of protons on rubid-
ium is that protons alter a rate constant that is not in-
volved with extracellular cation binding. For this analy-
sis, we start with the fact that an increase in extracellu-
lar proton concentration causes a decrease in the
apparent Km for rubidium. In general Km is not equal
to the Kd for rubidium, but rather reﬂects a number of
rate constants in the cycle. Thus, in theory, it is possible
for protons to alter the Km by altering another step in
the cycle and not the binding or release of extracellular
potassium. Consider a model with two rate limiting
steps, sodium efﬂux and potassium inﬂux, and that the
binding of proton and potassium occurs between these
steps and is rapid. In this case, it is easy to show that de-
creasing the sodium efﬂux rate–limiting step or in-
creasing the potassium inﬂux rate limiting step causes a
decrease in the apparent Km for rubidium. In fact, For-
bush and Klodos (1991) have shown, in an unsided
preparation, that protons alter the rate-limiting step,
causing a decrease in the sodium efﬂux half cycle and
an increase in the rate of potassium deocclusion. This
2Strictly speaking, the binding of two potassium ions could also cause
an access well to close, but in this case, no ion can traverse the well
and thus there is no electrical measurement to detect the access well.
But at some point in the cycle it must close so that it is closed when
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is exactly in the opposite direction to what is required
by our results. Thus it seems very likely that the proton
effects observed by Forbush and Klodos (1991) reﬂect
intracellular proton effects, as would be expected from
the work of Skou (1979), Skou and Esmann (1980),
and Breitweiser et al. (1987).
In conclusion, we have found that tetrapropylammo-
nium and bretylium have rubidium-like effects on ex-
tracellular proton binding that are different than the
sodium-like effects of guanidinium. In addition, pro-
tons bind at least 25-fold better to the rubidium-loaded
pump than to the sodium-loaded pump in both human
and rat red blood cells. This change in Kd for extracel-
lular protons reﬂects a conformational change due to
extracellular cation binding and seems unlikely to be
related to the conformational change that opens the
access well.
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